Skip to main content
TipRanks
Go Ultimate75% OFF

Calumet Specialty Products (CLMT) AI Stock Analysis

406 Followers
CLMT

Calumet Specialty Products

(NASDAQ:CLMT)

Select Model
Rating:49Neutral
Price Target:$32.00â–²(0.57% Upside)
Action:reiterated
Date:11/07/26

Overall score reflects high fundamental risk despite improving operating momentum: strong recent cash flow is offset by ongoing losses and a severely negative equity position. Technicals also weigh on the score due to bearish trend and weak momentum. Offsetting these, the latest earnings call provided a notably constructive outlook with strong EBITDA performance, meaningful deleveraging progress, and specific, scaled SAF expansion targets.

Positive Factors
Strong recent cash generationRecent operating and free cash flow provide internal funding for debt reduction, reliability work, and growth initiatives. Although historical cash generation has been volatile, the current improvement strengthens liquidity and gives management more flexibility to execute without relying entirely on external capital.
Negative Factors
Severely negative equityDeeply negative equity indicates a stressed capital structure and leaves a limited balance-sheet cushion against operating setbacks. This condition can constrain financial flexibility, complicate capital allocation, and make sustained cash generation and debt reduction especially important to long-term stability.

Calumet Specialty Products (CLMT) vs. SPDR S&P 500 ETF (SPY)

-50%0%50%100%150%200%250%CLMT+74.64%SPY+11.73%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
$2.80B
Dividend Yield
―
Average Volume (3M)
1.46M
Price to Earnings (P/E)
-14.2
Beta (1Y)
0.75
Revenue Growth
28.37%
EPS Growth
-407.11%
Country
US
Employees
1,540
Sector
Basic Materials
Sector Strength
61
Industry
Chemicals - Specialty

Calumet Specialty Products Business Overview & Revenue Model

Company Description

Calumet, Inc. engages in the manufacturing, formulation, and sale of specialty branded products and renewable fuel. It operates through the following segments: Specialty Products and Solutions, Montana/Renewables, Performance Brands, and Corporate. T...

How the Company Makes Money

Calumet makes money by processing crude oil and other hydrocarbon feedstocks in its refining and specialty production facilities and selling the resulting products at market-based prices. Its earnings are generally driven by (a) the margin between in...

Calumet Specialty Products Earnings Call Summary

Earnings Call Date:Nov 06, 2026(Q3-2026)|% Change Since:-26.60%|Next Earnings Date:Feb 26, 2027
Earnings Call SentimentPositive

The call was strongly positive, driven by record adjusted EBITDA, exceptional Specialty Products and Solutions margins, record Montana Renewables performance, substantial debt reduction, lower leverage, successful completion of the Shreveport turnaround, and a substantially less capital-intensive MaxSAF expansion. The principal challenges were Performance Brands' EBITDA decline from higher input costs and pricing lag, catalyst damage and reduced Montana Renewables rates, temporary turnaround and tie-in downtime, and the possibility that current specialty margins will gradually moderate as global capacity and inventories are restored.

Positive Updates

Exceptional Third-Quarter Financial Performance
Calumet generated $347 million of adjusted EBITDA with tax attributes in the third quarter. Specialty Products and Solutions contributed $248 million, while Montana Renewables delivered a record $80.4 million.

Negative Updates

Specialty Capacity Disruptions Could Persist
Management said the more than 10% of global paraffinic base-oil capacity that is damaged will not be a quick fix because high-processing-complex facilities require quarters to repair, recommission, and requalify, followed by a gradual rebuilding of inventories and supply chains.

Company Guidance

Management expects Montana Renewables to reach an 80 million annual gallon SAF run rate by year end, 120 million plus by spring, 120 to 150 million by the end of 2027, and ultimately, to 200 million gallons in 2028, while increasing throughput to 17 thousand barrels a day throughout the project. Specialty sales volumes of 20 thousand barrels a day are viewed as a floor, and after the Shreveport turnaround production is expected to move from the mid forties of thousands barrels a day to the fifties of thousands barrels a day making its own feedstock. Specialty margins are expected to remain pretty similar here for the foreseeable future; the company is not calling for $150 million of SPS to be the new norm forever, does not see a decline in the near future, and said what it did here is pretty reasonable to look at going forward, excluding the Shreveport turnaround and seasonality. The Shreveport turnaround and Montana Renewables and CMR tie in are each expected to take a little bit less than a month, while CMR is expected to generate positive EBITDA going forward, though not as much as it was operating at a full refinery. Calumet plans to continue using cash generated across all businesses to reduce the remaining $175 million of 2028 notes and the 2029 notes callable at par in January of 27.

Calumet Specialty Products Financial Statement Overview

Summary

Mixed fundamentals: revenue is rebounding (+13.2% TTM) and cash generation is strong (TTM operating cash flow $341.1M; free cash flow $265.1M), but profitability remains weak with a sizable TTM net loss (-$193.8M) and the balance sheet is highly strained with deeply negative equity (~-$870.7M TTM), which elevates financial risk.

Income Statement

44Neutral

Balance Sheet

24Negative

Cash Flow

67Positive
Financial statement breakdown
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue5.20B4.14B4.19B4.18B4.69B3.15B
Gross Profit471.00M245.70M230.80M451.70M351.70M142.90M
EBITDA-39.00M238.40M164.50M418.20M104.30M-1.40M
Net Income-193.80M-33.80M-222.00M48.10M-169.80M-254.90M
Balance Sheet
Total Assets2.99B2.69B2.76B2.75B2.74B2.13B
Cash, Cash Equivalents and Short-Term Investments225.20M125.10M38.10M7.90M35.20M38.10M
Total Debt2.17B2.46B2.37B2.19B1.89B1.76B
Total Liabilities3.60B3.18B3.22B3.00B3.03B2.51B
Stockholders Equity-870.70M-732.70M-712.80M-491.60M-533.60M-388.90M
Cash Flow
Free Cash Flow265.10M56.60M-123.10M-286.70M-435.60M-126.90M
Operating Cash Flow341.10M108.90M-46.40M-14.90M100.60M-44.00M
Investing Cash Flow-76.50M44.10M-76.70M-271.80M-286.00M-82.80M
Financing Cash Flow-179.40M6.20M154.30M266.20M98.70M139.30M

Calumet Specialty Products Technical Analysis

Technical Analysis SentimentNegative
Last Price31.82

Price Trends

50DMA50.99Negative
100DMA47.55Negative
200DMA39.56Negative

Market Momentum

MACD-5.46Positive
RSI20.44Positive
STOCH4.23Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CLMT, the sentiment is Negative. The current price of 31.82 is below the 20-day moving average (MA) of 43.17, below the 50-day MA of 50.99, and below the 200-day MA of 39.56, indicating a bearish trend. The MACD of -5.46 indicates Positive momentum. The RSI at 20.44 is Positive, neither overbought nor oversold. The STOCH value of 4.23 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for CLMT.

Calumet Specialty Products Risk Analysis

Calumet Specialty Products disclosed 46 risk factors in its most recent earnings report. Calumet Specialty Products reported the most risks in the "Finance & Corporate" category.

Higher RiskSector Avg.Lower RiskFinance & CorporateTech & InnovationLegal & RegulatoryProductionAbility to SellMacro & Political
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy

Latest Risks Added

3 New Risks
1.We have remediated the material weaknesses previously reported in our internal control over financial reporting, but if we identify additional material weaknesses in the future or fail to maintain an effective system of internal control we may not be able to accurately and timely report our financial results, which may affect investor confidence and cause us to incur additional costs resulting in adverse impacts to our results of operations.Q4, 2025
2.Our business involves the transportation by rail of crude oil, which involves risks of derailment, accidents and liabilities associated with cleanup and damages, as well as regulatory changes that may adversely impact our business, financial condition or results of operations.Q4, 2025
3.We are currently unable to fully utilize the CFPCs that we generate, and as such, we are exposed to fluctuations in the market prices of CFPCs and the potential unavailability of third parties willing to purchase CFPCs.Q4, 2025

Calumet Specialty Products Peers Comparison

Overall Rating

UnderperformOutperform
Sector (61)

Financial Indicators

CLMT against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
IOSPIOSP72Outperform$1.92B13.7310.42%2.38%4.73%―
EMNEMN65Neutral$7.13B11.0110.63%5.39%0.40%-6.58%
LYBLYB65Neutral$19.62B15.2612.39%5.67%-1.80%―
Sector *61Neutral$10.43B7.12-0.05%2.87%2.86%-36.73%
CLMTCLMT49Neutral$2.80B-14.1820.49%―28.37%-407.11%
NGVTNGVT48Neutral$2.00B33.58134.01%―-11.62%―
KOPKOP42Neutral$551.86M-5.82-20.07%1.19%-0.85%-693.89%

* Basic Materials Sector Average

Performance Comparison

0%50%100%150%200%CLMTEMNIOSPKOPLYBNGVTDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
CLMT and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
CLMTCalumet Specialty Products31.8213.1270.16%
EMNEastman Chemical Company62.307.6013.89%
IOSPInnospec78.018.8012.71%
KOPKoppers29.361.876.82%
LYBLyondellbasell Industries60.6920.4650.88%
NGVTIngevity59.2810.7722.20%

Calumet Specialty Products Corporate Events

Business Operations and StrategyPrivate Placements and FinancingRegulatory Filings and Compliance

Calumet Specialty Boosts Credit Facility, Enhancing Liquidity

Positive
Sep 15, 2026

On September 11, 2026, Calumet, Inc. entered into an Eleventh Amendment to its Third Amended and Restated Credit Agreement, boosting lender commitments from $500 million to $600 million, subject to borrowing base limits. The larger facility enhances...

Business Operations and StrategyPrivate Placements and Financing

Montana Renewables Unveils Capital-Efficient SAF Expansion Plan

Positive
Sep 1, 2026

On August 28, 2026, Montana Renewables and the U.S. Department of Energy amended their existing loan guarantee agreement to reflect a redesigned, more capital‑efficient expansion of the Great Falls renewable fuels facility. The project shifts from a...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 07, 2026